Simultaneous Liver Transplant, Sleeve Gastrectomy Beneficial
By Elana Gotkine HealthDay Reporter
FRIDAY, May 9, 2025 -- Simultaneous liver transplant and sleeve gastrectomy (LTSG) yield durable weight loss, resolution of diabetes and hypertension, and a reduction in allograft steatosis development, according to a study recently published online in the Journal of Hepatology.
Ellen L. Larson, M.D., from the William Von Liebig Center for Transplantation at the Mayo Clinic College of Medicine Rochester in Minnesota, and colleagues conducted a retrospective cohort study involving 72 patients undergoing LTSG and 185 patients with body mass index (BMI) >30 kg/m2 who underwent LT alone for metabolic-associated steatotic liver disease.
The researchers observed no significant difference in mortality and graft loss for LT versus LTSG patients. A significantly lower prevalence of diabetes was seen for more than eight years for post-LTSG patients, while hypertension decreased from 61.1 to 38.5 percent. Compared with baseline, significant weight loss was seen for more than nine years for LTSG patients, with an average baseline BMI of 45.5 kg/m2. No significant change in BMI or diabetes was seen for LT patients, who had an average baseline BMI of 34.0 kg/m2. Allograft steatosis development was significantly lower in LTSG versus LT patients. The prevalence of fibrosis was reduced in LTSG versus LT patients at three to 10 years postoperatively, although the reduction was not significant.
"Given the rising obesity epidemic world-wide, it is essential to find solutions that provide increased transplant access and improved metabolic outcomes for this complex patient population," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
PFAS Exposure Linked to Teen Weight Regain After Bariatric Surgery
TUESDAY, Aug. 19, 2025 -- For adolescents, exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) is associated with weight regain after bariatric surgery, according to...
Saliva Insulin Can Differentiate Hyperinsulinemia in Normoglycemic People
MONDAY, Aug. 18, 2025 -- Saliva insulin can differentiate between normal and hyperinsulinemic responses among normoglycemic adults with different body mass index (BMI) classes...
26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024
THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.